RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Medipharm Labs Stock

Medipharm Labs ROE 2024

Medipharm Labs ROE

-0.25

Ticker

LABS.TO

ISIN

CA58504D1006

WKN

A2N7AA

In 2024, Medipharm Labs's return on equity (ROE) was -0.25, a -53.93% increase from the -0.54 ROE in the previous year.

Medipharm Labs Aktienanalyse

What does Medipharm Labs do?

MediPharm Labs Corp is a leading company in the cannabis industry, specializing in the production of specialized, high-quality cannabis products. The company was founded in 2015 by founders Pat McCutcheon and Keith Strachan and is headquartered in Barrie, Ontario, Canada. Medipharm Labs ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Medipharm Labs's Return on Equity (ROE)

Medipharm Labs's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Medipharm Labs's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Medipharm Labs's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Medipharm Labs’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Medipharm Labs stock

What is the ROE (Return on Equity) of Medipharm Labs this year?

The ROE of Medipharm Labs this year is -0.25 undefined.

How has the Return on Equity (ROE) of Medipharm Labs developed compared to the previous year?

The ROE of Medipharm Labs has increased by -53.93% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Medipharm Labs?

A high ROE indicates that Medipharm Labs generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Medipharm Labs?

A low ROE can indicate that Medipharm Labs is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Medipharm Labs affect the company?

A change in ROE (Return on Equity) of Medipharm Labs can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Medipharm Labs?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Medipharm Labs?

Some factors that can influence Medipharm Labs's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Medipharm Labs pay?

Over the past 12 months, Medipharm Labs paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Medipharm Labs is expected to pay a dividend of 0 CAD.

What is the dividend yield of Medipharm Labs?

The current dividend yield of Medipharm Labs is .

When does Medipharm Labs pay dividends?

Medipharm Labs pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Medipharm Labs?

Medipharm Labs paid dividends every year for the past 0 years.

What is the dividend of Medipharm Labs?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Medipharm Labs located?

Medipharm Labs is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medipharm Labs kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medipharm Labs from 12/12/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.

When did Medipharm Labs pay the last dividend?

The last dividend was paid out on 12/12/2024.

What was the dividend of Medipharm Labs in the year 2023?

In the year 2023, Medipharm Labs distributed 0 CAD as dividends.

In which currency does Medipharm Labs pay out the dividend?

The dividends of Medipharm Labs are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Medipharm Labs

Our stock analysis for Medipharm Labs Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medipharm Labs Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.